Conclusions
lung cancer, cancer, Lung cancer, cancer deaths
LUNG CANCER, CANCER, LUNG CANCER, LUNG
Weekly PRO symptom monitoring statistically and clinically significantly improves HRQOL in lung cancer patients. The logistically less intensive, reactive approach may be a better fit for implementation.Lung cancer is the second most common cancer diagnosed worldwide, and the most common cause of cancer deaths per year (Previous randomized controlled trials (RCTs) investigated the effect of patient-reported outcomes (PRO) symptom monitoring on overall survival and HROQL. These studies reported significantly better HRQOL and overall survival compared with care as usual (A more ‘reactive’ patient-centered approach in which the patient receives the alert and is encouraged to contact the hospital following an alert might be equally effective while significantly lowering the workload for the health-care providers. The primary aim of the SYMPRO–Lung study was to compare the effect of weekly online PRO symptom monitoring via a reactive approach (patient receives alert) or an active approach (health-care provider receives alert) with care as usual on the HRQOL of lung cancer patients at 15 weeks after start of treatment.